Navigation Links
Focus 28 Begins Shipping Next Generation Line of Meal Replacements and Food Supplements for Bariatric Patients
Date:9/9/2008

TARRYTOWN, N.Y., Sept. 9 /PRNewswire/ -- Focus 28, Inc. announced today that it has started shipping Bariatric RX, its new next generation line of meal replacements and nutritional supplements designed to meet the specific nutritional needs of bariatric patients. According to the company, Bariatric RX not only features some great tasting products, the food supplements also utilize Double A Technology (AAT), a unique nutritional delivery system.

Since bariatric bypass patients cannot rely on the stomach's digestive systems to facilitate absorption of many of the essential vitamins and minerals the body requires to remain healthy, Bariatric RX's new formulations represent breakthrough products for this population. "Double A Technology," reports Mitch Suss, Focus 28's CEO, "accelerates the absorption of the specially formulated vitamins and minerals contained within the Bariatric RX supplements making it an ideal solution for this patient group."

"We consulted bariatric surgeons, nutritionists, chemists and other specialists in the field of Bariatrics to develop the Bariatric RX line," Mr. Suss, explains. "I am proud to say we have developed a first of its kind line of meal replacements and nutritional supplements -- with great tastes and a new delivery system -- that meets many of the needs patients who have been treated surgically for extreme obesity."

The Bariatric RX line includes Bariatric RX Meal Replacements and Bariatric RX Bariatric Nutritional Supplements. The Bariatric RX nutritional supplements include Chewable Zinc Plus Fiber Plus (Powder), Sublingual B-12, Chewable Multi Vitamin, Chewable Gentle Iron. Chewables are available in cherry, vanilla and citrus flavors. Bariatric RX meal replacements are available in 20.5 oz (580 grams) containers, including: Sensational Chocolate Supreme, World Class Vanilla, Banana Creme Delight.

In addition to its new line of products, Focus 28 recently launched its new website,

SOURCE Focus 28, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
2. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
3. Education Key Focus of Michigan Policy Summit
4. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
5. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
6. This October, the American Physical Therapy Associations National Physical Therapy Month to Focus on Nations Obesity Epidemic
7. DuPont Focused on Meeting Global Demands for Greater Safety & Protection
8. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
9. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
10. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
11. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 01, 2015 Franklin University, one of ... announce the establishment of the Greta J. Russell Medical ... possible through the generous gift of $100,000 from Medical ... behalf of Medical Mutual to University representatives, Dr. ... of Advancement & Strategic Relations. , “We are ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Pricing Healthcare ... last several months, bring coverage to a third of all ... states of Massachusetts, Kansas, and Iowa, and the first dedicated eye ... center in Dallas, TX was also added. , In addition, the ... to and general interest in the platform continue to grow across ...
(Date:4/1/2015)... Patients with inoperable mesothelioma may soon ... to the FDA’s approval of CRS-207’s orphan drug application ... on the Surviving Mesothelioma website. , CRS-207 ... of the bacteria that causes the food-borne illness Listeriosis. ... funding and other incentives to support continued testing and ...
(Date:4/1/2015)... 2015 Phybridge Inc., a provider ... today its strategic partnership with SaskTel in a ... the businesses of Saskatchewan. SaskTels’ Integrated Business Communications ... that offers users a hosted IP unified communications ... The objective of IBC is to offer an ...
(Date:4/1/2015)... 01, 2015 The dearth of ... are set to retire in the next five ... demand for laboratory automation. The application of advanced ... it ensures timely progress and efficiency with minimal ... lab automation in high-throughput screening, combinatorial chemistry, automated ...
Breaking Medicine News(10 mins):Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3Health News:Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 3Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 2Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 3
... LUGANO, Switzerland, September 9 As part ... been appointed as new,CEO in the American subsidiary, Helsinn ... Officer of the recently acquired,Helsinn Therapeutics, and has held ... Development and in Research. , ...
... ... Patient Education Reference Center™ Available online at www.ebscohost.com/flu . The Latest Evidence-based ... ... -- Concerns about Pandemic H1N1 and the upcoming flu season have people on alert ...
... ... Year , ... GA (PRWEB) September 9, 2009 -- Kennesaw, Georgia-based Cobb Pediatric Therapy Services, a pediatric ... systems across the U.S., has been named one of the country,s fastest growing private ...
... ... Inc. today announced the completion of over a dozen more HL7 ... in the medical industry. pMDsoft,s industry-leading interface engine has allowed ... data entry and increasing the accuracy of their claims. The ...
... , - Choosing a More Appropriate ... to Improvement , The first results of ... presented today at the 6th congress,of the European Federation of Chapters ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090909/358726 ) , ...
... owners and employees are among those who stand to ... current health reform proposals under consideration by Congress according ... to extend health care coverage to everyone and repair ... costs, high broker fees, underwriting, and a lack of ...
Cached Medicine News:Health News:New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group's American subsidiary, Helsinn Therapeutics (U.S.) Inc. 2Health News:EBSCO Publishing Makes Evidence-Based Flu Resources Freely Available 2Health News:EBSCO Publishing Makes Evidence-Based Flu Resources Freely Available 3Health News:Cobb Pediatric Therapy Services Is Recognized by Inc. Magazine as One of the Fastest Growing Private Companies 2Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 2Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 3Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 4Health News:pMDsoft Announces Interfaces with Additional EMR, EHR, Practice Management, Hospital and Billing Systems 5Health News:First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 2Health News:First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 3Health News:Small businesses would see lower costs, more comprehensive coverage from health reform 2Health News:Small businesses would see lower costs, more comprehensive coverage from health reform 3
(Date:4/1/2015)... , April 1, 2015  Galmed Pharmaceuticals Ltd. ... company focused on the development and commercialization of ... liver diseases and cholesterol gallstones, today announced that ... Vice President of Clinical Operations. Mr. ... clinical operations, development and regulatory affairs.  From 2005 ...
(Date:4/1/2015)... Minn. , April 1, 2015  EnteroMedics ... devices using neuroblocking technology to treat obesity, metabolic ... the Company has entered into a partnership with ... access to vBloc® Therapy, delivered via the Maestro® ... System is approved for adults with a BMI ...
(Date:3/31/2015)... and ORANGEBURG, N.Y., March 31, 2015 Uroplasty, ... announced the completion of their merger. The merger ... of the all-stock combination creates a new medical ... April 1, 2015, Cogentix Medical, Inc. will trade ... Medical will have its U.S. headquarters in ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 2Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 3EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 2EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 3EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 4Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4
... show evidence of additional protection,against infection with ... 17, 2007 /PRNewswire-FirstCall/ -- The,GlaxoSmithKline cervical cancer ... preventing precancerous,lesions due to cancer-causing human papillomavirus ... years in an extended follow-up trial, according ...
... Alnylam,Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi ... for Cancer,Research (AACR) 2007 Annual Meeting that ... ALN-VSP01, for the,treatment of liver cancer and ... program. ALN-VSP01 is an RNAi therapeutic that ...
Cached Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5
... Captia™ Mumps IgG Enzyme- linked Immunosorbent Assay ... quantitative determination of IgG antibody to Mumps ... may be used for the determination of ... may be used to demonstrate seroconversion or ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
... The TEG system is comprised of the TEG ... provide a complete picture of the formation and ... imbalance of the two systems. ,Haemoscope's TEG analyzer ... market that follows the reliable and proven model ...
... of diseases of the thoracic aorta has ... in the chest to place a synthetic ... method can result in long hospital stays ... is seeking less invasive alternatives to this ...
Medicine Products: